companydata.dkcompanydata.dk

Novomedicon ApS: Financial statements 2022

CVR: 38818791

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

Novomedicon ApS (CVR 38818791) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -6,982 and a net result of DKK -7,312 compared with DKK -522 the year before. Equity in the 2022 report amounted to DKK 27,523. The solvency ratio was 3.7%.

Gross Profit
DKK -6,982
Profit/Loss
DKK -7,312
Equity
DKK 27,523
Total Assets
DKK 743,822

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022--7K-7K28K-
2021---52235K-
2020-0-5K-5K1
2019-001001
20180000-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Novomedicon ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Novomedicon ApS: The 2021 annual report is outJun 22, 2022

Novomedicon ApS has published its annual report for 2021. The net result was DKK -522.

About Novomedicon ApS

Novomedicon ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2017. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named Novomedicon IVS. The management consists of Jens Dahlgaard Hove. The company is owned by Jens Dahlgaard Hove. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -7,598 and a net result of DKK -7,598 compared with DKK -7,538 the year before. Equity in the 2025 report amounted to DKK 5,125.

Source: annual report 2025, Danish Business Authority

Other financial years